Join to view full profile
301 SE Ocean BlvdSte 102Stuart, FL 34994
Phone+1 772-287-4061
Fax+1 772-287-4176
Dr. Friedman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elke Friedman is an oncologist in Richmond, VA and is affiliated with multiple hospitals in the area, including Henrico Doctors' Hospital, Bon Secours St. Francis Medical Center, Bon Secours Memorial Regional Medical Center, Chippenham Hospital, and Bon Secours St. Mary's Hospital. She received her medical degree from Medical College of Wisconsin and has been in practice 21 years. She specializes in hematologic oncology and is experienced in bronchial cancer and general / benign hematology.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1996 - 1999
Medical College of WisconsinClass of 1996
Certifications & Licensure
FL State Medical License 2026 - 2028
VA State Medical License 1997 - 2028
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2014-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- 45 citationsProspective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung...Michael A. Pritchett, D. Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol
JCO Precision Oncology. 2019-04-25 - 131 citationsRandomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung CancerDavid R. Spigel, Howard A. Burris, F. Anthony Greco, Dianna Shipley, Elke K. Friedman
Journal of Clinical Oncology. 2011-06-20
Press Mentions
Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist and Hematologist Elke K. Friedman, MD to Stuart Cancer CenterJune 3rd, 2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
